Subscribe to stay informed!
Malvern-based Endo Health Solutions has been ordered to pay over $1.5 billion in criminal financial penalties after the company admitted to falsely marketing…
Endo Inc., formed as a result of Malvern-based Endo International’s bankruptcy reorganization plan, has finalized the acquisition of most of the assets of…
Malvern-based Endo International received court approval earlier this week for its reorganization plan, over 18 months after the company filed for Chapter 11 bankruptcy…
Malvern-based Endo International has agreed to pay up to $465 million over several years to settle federal civil and criminal charges over its marketing…
Endo International, the Ireland-based biopharmaceutical company with U.S. headquarters in Malvern, is on track to finally emerge from bankruptcy after reaching a deal…
Malvern-based Endo International is officially up for bidding. A U.S. Bankruptcy Court has approved the auction, and bidding procedures can begin at $6…
Lawyers and federal agencies are arguing that Malvern-based drug maker Endo is still profiting from the disgraced oxymorphone pill also known as Opana ER…
Malvern-based Vanguard Group has expanded its office space in the Philadelphia area with the purchase of a nine-year-old high-end office complex…
Malvern opioid maker Endo International has the greenlight to pay $93,000 in incentives to employees and sales reps, writes Bob Fernandez for The Philadelphia…
Seven state attorneys general, including Pennsylvania AG Josh Shapiro, and a federal bankruptcy overseer appointed by the court, are objecting to the $94 million paid…
After struggling with the debt incurred due to opioid litigation settlements, Endo International, the Ireland-based pharmaceutical company with U.S. headquarters in Malvern, has…
Endo International, the pharmaceutical giant based in Dublin, Ireland, with U.S. headquarters in Malvern, is expected to file for Chapter 11 bankruptcy protection, a…
Endo International, the Dublin-based pharmaceutical company with its U.S. headquarters in Malvern, recently disclosed in a filing with the SEC that it will…
Endo International, which has its U.S. headquarters in Malvern, has decided on a unique tagline for its latest marketing program for cellulite treatment Qwo…
Endo International, the Dublin-based pharmaceutical company with U.S. headquarters in Malvern, reached a $50 million settlement to resolve three opioid cases in New…
Endo International — based in Dublin, Ireland, with a U.S. headquarters in Malvern — has hired a financial restructuring firm to navigate its current legal morass…
Endo Health Solutions and Endo Pharmaceuticals — subsidiaries of Endo International, which is based in Dublin, Ireland, and has its U.S. headquarters in Malvern — have…
After pushing the launch of its new cellulite treatment, Qwo, to this spring due to the pandemic, Malvern-based Endo International has been building momentum…
Before we send you to this site, please subscribe to our daily newsletter.